A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The objective of the study is to assess the safety, efficacy, optimum dosage, and dosing regimen of K‐161 in adult subjects with moderate to severe dry eye disease.
Epistemonikos ID: 96f0e74d010c79c86fb0c6651f52e36da5c9416b
First added on: May 22, 2024